Latest traumatic brain injury Stories
Investigating feasibility of NSI-189 trial to treat cognitive and psychiatric impairment from traumatic brain injury ROCKVILLE, Md., April 24, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that it is working with the National Football League Alumni Association (NFLAA), based in Newark, NJ, to develop a trial for treating NFL alumni members suffering from traumatic brain injuries (TBI), with NSI-189, the lead compound in the company's neurogenic drug platform....
Recently, the Rhode Island and Southeastern Massachusetts personal injury law firm d’Oliveira & Associates released a new informational graphic regarding up-to-date statistics and causes of traumatic brain injuries. (PRWEB) April 22, 2013 The Center for Disease Control and Prevention (CDC) explains that, while Traumatic Brain Injuries (TBIs) can range from mild to severe, nearly 1.7 million Americans suffer one each year and a contributing factor to over 30% of all injury-related...
ROCKVILLE, Md., April 22, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that it has received approval from the Food and Drug Administration (FDA) to begin dosing the third and final cohort of patients in its ongoing Phase Ib to test the safety of NSI-189 in the treatment of major depressive disorder (MDD). NSI-189, the lead compound in Neuralstem's neurogenic small molecule platform, is a proprietary new chemical entity that stimulates new neuron growth in the...
Newspapers are paying more attention to the severity and long-term impact of concussions and other traumatic brain injuries in ice hockey than they did 25 years ago, a new study has found. They’re also writing more stories about the need to act against aggression, especially at youth levels, and reporting about concussions suffered by a wide range of players, not just stars. However, newspapers are still reporting that head injuries “are just part of the game” and that hockey...
Popular media perspectives on traumatic brain injuries (TBI) in sports like ice hockey has changed over time and may influence people's attitudes towards these injuries, according to research published April 17 in the open access journal PLOS ONE by Michael Cusimano and colleagues from St. Michael's Hospital, Toronto, Canada. The authors compared articles published in the Chicago Tribune, New York Times, Toronto Star and Vancouver Sun from 1998-2000 and 2009-2011. They found the Canadian...
ROCKVILLE, Md., April 18, 2013 /PRNewswire/ -- Neuralstem, Inc. (NYSE MKT: CUR) announced that CEO and President, Richard Garr, will take part in a comprehensive Bio Maryland panel, introduced by Lt. Governor, Anthony Brown, on Maryland's leadership in traumatic brain injury prevention, diagnosis and treatment at the BIO International Convention in Chicago, Ill., on April 24. Mr. Garr's panel, from 2:30 - 3:30, will discuss "Treatment--What's Working and What is Under Development." He...
Investigational Treatment for Mild Traumatic Brain Injury to be Studied in Phase I Trial Later This Year BANGKOK, April 18, 2013 /PRNewswire-USNewswire/ -- Besins Healthcare (Besins) and Shin Nippon Biomedical Laboratories (SNBL), a global leader in hormonal products, announced today that they have completed a licensing agreement to use SNBL's proprietary intranasal drug delivery system, Muco(TM) System, to further develop its BHR-310 investigational agent containing progesterone for...
Neurological Wellness Center Comments on Alzheimer’s Care Assisted Living Expenses Costing $90 to $200 Per Day According to a Recent Article in the Los Angeles Times* (PRWEB) April 17, 2013 Implementing the treatment detailed in Perispinal etanercept: a new therapeutic paradigm in neurology by Dr. Tobinick can enable a severely impaired person needing full time assisted living care who is unable to recognize their own children or even count to ten to, after a single dose, recognize...
Research grant provides foundation to propel additional financial support of One Mind's inaugural brain research program SEATTLE, April 15, 2013 /PRNewswire/ -- One Mind for Research announced today that Wounded Warrior Project® (WWP) has pledged $3.5 million in support of One Mind's "Gemini Program," contingent upon One Mind securing additional funding. "The Gemini Program" is a multi-year study of Traumatic Brain Injury (TBI) and Post-Traumatic Stress (PTS). One Mind is...
Study Evaluating Intravenous Progesterone Formulation BHR-100 Aims to Bring First-Ever Approved TBI Treatment to Market; Patient Enrollment Set to Complete in 2013 HERNDON, Va., April 15, 2013 /PRNewswire-USNewswire/ -- BHR Pharma, LLC announced today that the 1,000(th) patient has been enrolled in its SyNAPSe® clinical trial, a global phase III study evaluating the effectiveness of its proprietary intravenous progesterone infusion agent, BHR-100, to treat severe traumatic brain...
